Glenn Gregory M

Company

Date

Role

Action

Shares

Amount

Of holding

NVAX NOVAVAX INC

10 Mar 2023

President, R&D

Bought

1,000

$6.50K

7.4%

NVAX NOVAVAX INC

7 Mar 2023

President, R&D

Bought

2,000

$14.09K

17.4%

NVAX NOVAVAX INC

6 Mar 2023

President, R&D

Bought

3,000

$22.45K

35.4%

NVAX NOVAVAX INC

15 Dec 2021

President, R&D

Sold, plan not stated

1,686

$293.58K

22.9%

NVAX NOVAVAX INC

7 Dec 2021

President, R&D

Sold, plan not stated

8,250

$1.40M

67.0%

NVAX NOVAVAX INC

30 Nov 2021

President, R&D

Sold, plan not stated

8,942

$1.82M

68.8%

NVAX NOVAVAX INC

26 Nov 2021

President, R&D

Sold, plan not stated

2,083

$454.25K

33.9%

NVAX NOVAVAX INC

23 Nov 2021

President, R&D

Sold, plan not stated

8,250

$1.65M

67.0%

NVAX NOVAVAX INC

16 Nov 2021

President, R&D

Sold, plan not stated

8,250

$1.40M

67.0%

NVAX NOVAVAX INC

15 Nov 2021

President, R&D

Sold, plan not stated

1,183

$203.50K

22.6%

NVAX NOVAVAX INC

9 Nov 2021

President, R&D

Sold, plan not stated

8,250

$1.38M

67.0%

NVAX NOVAVAX INC

2 Nov 2021

President, R&D

Sold, plan not stated

8,250

$1.52M

67.0%

NVAX NOVAVAX INC

29 Oct 2021

President, R&D

Sold, plan not stated

680

$100.87K

14.3%

NVAX NOVAVAX INC

26 Oct 2021

President, R&D

Sold, plan not stated

10,334

$1.37M

71.8%

NVAX NOVAVAX INC

19 Oct 2021

President, R&D

Sold, plan not stated

8,250

$1.36M

67.0%

NVAX NOVAVAX INC

15 Oct 2021

President, R&D

Sold, plan not stated

1,183

$201.11K

22.6%

NVAX NOVAVAX INC

12 Oct 2021

President, R&D

Sold, plan not stated

8,250

$1.35M

67.0%

NVAX NOVAVAX INC

5 Oct 2021

President, R&D

Sold, plan not stated

8,250

$1.44M

67.0%

NVAX NOVAVAX INC

30 Sep 2021

President, R&D

Sold, plan not stated

693

$143.62K

14.6%

NVAX NOVAVAX INC

27 Sep 2021

President, R&D

Sold, plan not stated

2,083

$488.32K

33.9%

NVAX NOVAVAX INC

15 Sep 2021

President, R&D

Sold, plan not stated

1,183

$271.30K

22.6%

NVAX NOVAVAX INC

31 Aug 2021

President, R&D

Sold, plan not stated

1,386

$332.46K

25.4%

NVAX NOVAVAX INC

26 Aug 2021

President, R&D

Sold, plan not stated

4,167

$974.74K

50.6%

NVAX NOVAVAX INC

16 Aug 2021

President, R&D

Sold, plan not stated

1,866

$435.75K

31.5%

NVAX NOVAVAX INC

20 Jul 2021

President, R&D

Sold, plan not stated

2,409

$518.98K

46.1%

NVAX NOVAVAX INC

15 Jul 2021

President, R&D

Sold, plan not stated

5,654

$1.01M

66.8%

NVAX NOVAVAX INC

17 Jun 2021

President, R&D

Sold, plan not stated

2,411

$441.89K

46.2%

NVAX NOVAVAX INC

15 Jun 2021

President, R&D

Sold, plan not stated

5,716

$1.09M

67.0%

NVAX NOVAVAX INC

19 May 2021

President, R&D

Sold, plan not stated

2,385

$339.07K

45.9%

NVAX NOVAVAX INC

17 May 2021

President, R&D

Sold, plan not stated

5,712

$765.27K

67.0%

NVAX NOVAVAX INC

19 Apr 2021

President, R&D

Sold, plan not stated

2,417

$531.05K

46.2%

NVAX NOVAVAX INC

15 Apr 2021

President, R&D

Sold, plan not stated

5,712

$1.14M

67.0%

NVAX NOVAVAX INC

17 Mar 2021

President, R&D

Sold, plan not stated

2,423

$530.30K

46.3%

NVAX NOVAVAX INC

15 Mar 2021

President, R&D

Sold, plan not stated

5,712

$1.13M

67.0%

NVAX NOVAVAX INC

18 Feb 2021

President, R&D

Sold, plan not stated

2,434

$656.13K

46.4%

NVAX NOVAVAX INC

16 Feb 2021

President, R&D

Sold, plan not stated

5,712

$1.61M

67.0%

NVAX NOVAVAX INC

29 Sep 2020

President, R&D

Sold, plan not stated

19,949

$2.13M

92.7%

NVAX NOVAVAX INC

28 Sep 2020

President, R&D

Sold, plan not stated

25,000

$2.76M

53.8%

NVAX NOVAVAX INC

18 Aug 2020

President, R&D

Sold, plan not stated

55,921

$8.12M

96.8%

NVAX NOVAVAX INC

18 Jun 2020

President, R&D

Sold, plan not stated

16,749

$997.10K

90.1%

NVAX NOVAVAX INC

31 Jan 2020

President, R&D

Bought

1,250

$4.83K

×10

NVAX NOVAVAX INC

13 Sep 2019

President, R&D

Sold, plan not stated

9,620

$59.48K

98.7%

NVAX NOVAVAX INC

13 May 2019

President, R&D

Bought

1,000

$5.85K

1.4%

NVAX NOVAVAX INC

31 Jan 2019

President, R&D

Bought

13,168

$11.59K

21.9%

NVAX NOVAVAX INC

31 Jul 2018

President, R&D

Bought

13,007

$11.45K

27.6%

NVAX NOVAVAX INC

14 May 2018

President, R&D

Bought

20,000

$32.80K

73.5%

NVAX NOVAVAX INC

31 Jan 2018

President, R&D

Bought

12,784

$11.25K

88.6%

NVAX NOVAVAX INC

9 Nov 2017

President, R&D

Bought

10,000

$11.30K

226%

NVAX NOVAVAX INC

7 Dec 2016

President, R&D

Bought

1,000

$1.45K

29.2%

NVAX NOVAVAX INC

21 Sep 2016

President, R&D

Bought

1,000

$1.65K

41.2%

NVAX NOVAVAX INC

31 Jan 2016

SVP, Research and Development

Bought

2,369

$10.38K

×41

NVAX NOVAVAX INC

16 Dec 2015

SVP, Research and Development

Sold, plan not stated

61,886

$530.70K

99.9%

NVAX NOVAVAX INC

18 Aug 2015

SVP, Research and Development

Sold, plan not stated

15,000

$202.74K

92.8%

NVAX NOVAVAX INC

31 Jul 2015

SVP, Research and Development

Bought

892

$2.03K

335%

NVAX NOVAVAX INC

31 Jan 2015

SVP, Research and Development

Bought

866

$1.97K

opened

NVAX NOVAVAX INC

26 Sep 2014

SVP, Research and Development

Sold, plan not stated

16,809

$69.93K

100%

NVAX NOVAVAX INC

31 Jul 2014

SVP, Research and Development

Bought

12,707

$28.97K

310%

NVAX NOVAVAX INC

14 Mar 2014

SVP, Research and Development

Sold, plan not stated

29,000

$158.78K

87.6%

NVAX NOVAVAX INC

31 Jan 2014

SVP, Research and Development

Bought

4,102

$9.39K

15.3%

NVAX NOVAVAX INC

7 Jun 2013

Chief Scientific Officer

Bought

1,000

$1.83K

3.3%

NVAX NOVAVAX INC

6 Jun 2013

Chief Scientific Officer

Bought

1,000

$2.01K

3.4%

NVAX NOVAVAX INC

10 May 2012

Chief Scientific Officer

Bought

25,000

$33.75K

625%

NVAX NOVAVAX INC

5 Dec 2011

Chief Scientific Officer

Bought

2,000

$3.00K

0.5%

NVAX NOVAVAX INC

29 Nov 2011

Chief Scientific Officer

Bought

2,000

$2.52K

0.5%

NVAX NOVAVAX INC

7 Apr 2011

Chief Scientific Officer

Sold, plan not stated

52,000

$133.12K

11.2%

NVAX NOVAVAX INC

25 Aug 2010

Chief Scientific Officer

Bought

2,000

$4.02K

opened